# Commentary: A multicenter, real-world cohort study: effectiveness and safety of Azvudine in hospitalized COVID-19 patients with pre-existing diabetes

**Authors:** Shixuan Guo, Jinyuan Zhang, Juan Shu

PMC · DOI: 10.3389/fendo.2026.1735040 · Frontiers in Endocrinology · 2026-01-20

## Full-text entities

- **Diseases:** diabetes (MESH:D003920), COVID-19 (MESH:D000086382)
- **Chemicals:** Azvudine (MESH:C540945)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12864116/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12864116/full.md

---
Source: https://tomesphere.com/paper/PMC12864116